WELL Health Technologies (TSE:WELL - Get Free Report) received a C$8.50 target price from investment analysts at TD in a research report issued on Monday, BayStreet reports. The brokerage presently has a "buy" rating on the stock. TD's price objective points to a potential upside of 90.16% from the stock's current price.
Separately, Canaccord Genuity Group boosted their price target on shares of WELL Health Technologies from C$6.50 to C$7.75 and gave the company a "buy" rating in a research note on Thursday, July 9th. Five analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, WELL Health Technologies currently has an average rating of "Buy" and an average price target of C$7.40.
Read Our Latest Stock Analysis on WELL
WELL Health Technologies Stock Up 3.7%
Shares of WELL traded up C$0.16 during trading hours on Monday, hitting C$4.47. The stock had a trading volume of 1,013,915 shares, compared to its average volume of 1,367,758. WELL Health Technologies has a 1-year low of C$3.58 and a 1-year high of C$6.08. The firm has a market capitalization of C$1.14 billion, a P/E ratio of 223.50, a price-to-earnings-growth ratio of -1.93 and a beta of 0.71. The firm has a 50 day simple moving average of C$4.25 and a 200-day simple moving average of C$4.21. The company has a debt-to-equity ratio of 100.05, a current ratio of 0.80 and a quick ratio of 1.02.
WELL Health Technologies (TSE:WELL - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported C$0.04 earnings per share for the quarter. WELL Health Technologies had a return on equity of 0.44% and a net margin of 0.25%.The business had revenue of C$400.43 million for the quarter. Sell-side analysts predict that WELL Health Technologies will post 0.3000698 EPS for the current fiscal year.
WELL Health Technologies Company Profile
(
Get Free Report)
WELL Health Technologies Corp. TSX: WELL is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.